The Colts activated Alec Pierce from the active/PUP list, putting the Indianapolis WR back on the practice field after he missed camp while recovering from offseason ankle surgery. The move means Pierce will not be forced to miss the first four games of the season, but it does not guarantee he will be ready for the opener.
PlayerProfiler highlights Pierce’s 98th-percentile College Yards Per Reception and 94th-percentile Breakout Age, while his 2025 profile was built around elite downfield usage. Pierce is back in the building, but the next two weeks will determine whether his fantasy discount is an opportunity or a trap.
Indianapolis Colts wide receiver Alec Pierce (hand, wrist) ...
Indianapolis Colts wide receiver Alec Pierce (heel) was a ...
Indianapolis Colts wide receiver Alec Pierce (ankle) "could...
The Keenan Allen signing gives Indianapolis a proven target earner on a one year, $8.32 million deal. Allen commanded 122 targets in 2025 for 81 receptions and 777 yards, while posting a 22.6% Target Share and 1.72 Yards Per Route Run.
Allen is back in the fantasy conversation, but the lack of a true field stretcher could put a ceiling on this passing attack. Allen’s 8.4-yard ADOT and 20% Deep Target Share make him another underneath option alongside Tyler Warren and Josh Downs, not a replacement for Alec Pierce’s vertical role. Warren already earned a 21.2% Target Share in 2025, while Downs posted a 17.5% share, so the Colts are creating a crowded ecosystem for short area targets.
Missing the entirety of training camp puts Alec Pierce on a tight one-month timeline to prepare for Week 1. Those lost reps stall his route-tree expansion after a campaign fueled by a No. 1 ranked 51.8-percent Air Yards Share and a 19.0 Average Target Distance.
Pierce will struggle to regain his 2025 upon return, clogging redraft rosters. Drafting him at cost carries more risk than reward. Pierce should be avoided in all fantasy football formats, including dynasty leagues.
After securing a four-year, $114 million extension on the heels of a 51.8-percent Air Yards Share, Alec Pierce faces risk of missing regular-season time following a second PRP injection for his delayed ankle recovery. Indianapolis committed WR1 money to a young player who commanded an 18.0-percent Target Share while trading away Michael Pittman.
Even after being activated, Pierce will require several weeks to gain full confidence in his lower body. Meanwhile, fellow starter Josh Downs is also dealing with a minor groin injury. When Downs returns, he and tight end Tyler Warren will be first in line absorb the vacated target volume during Pierce’s absence. Pierce is a sell and Downs and Warren are buys based on this injury alone. Even the forgotten Ashton Dulin‘s ADP is starting to creep up across all fantasy football draft formats.
UPDATE: Colts general manager Chris Ballard insists that Alec Pierce did not receive a second PRP injection. Stay tuned for the next episode of Anklegate.
Indianapolis wide receiver Josh Downs was spotted on the sideline in street clothes during practice with a groin injury, raising immediate concern for his early-season status. Coming off a season where he commanded a 23.6-percent Target Rate and a 70.5-percent Slot Rate, any missed time impacts a player heavily reliant on volume in the short-to-intermediate passing game.
The team expects an official update soon, but a soft-tissue setback this close to Week 1 threatens his projection as a high-floor fantasy asset. Downs remains a very strong WR pick in dynasty league start-ups as well as high-stakes and best ball formats.
Shane Steichen and the Colts front office are obscuring the timeline while Alec Pierce recovers from off-season ankle surgery. Coming off a campaign where he produced a 51.8-percent Air Yards Share (No. 1) and 21.3 Yards Per Reception (No. 2), a standard 4-to-6 month recovery window places his Week 1 status in doubt.
Fantasy managers drafting him as a WR3 are absorbing substantial risk until he logs actual practice reps. Pierce is falling each week in PlayerProfiler’s redaft rankings for 2026.